How a post-Brexit trade deal with the US could make life-saving drugs unaffordable for the NHS
The Independent

The UK is going to be at a distinct disadvantage in this negotiation – desperate for a deal the US could happily live without Can we be confident the UK won’t bow to US pressure and trade the interests of NHS patients for a deal that will fuel profits at big pharma? Don’t be so sure The fight over access to the life-changing cystic fibrosis medicine Orkambi, is emblematic of the challenge facing the NHS from ever-higher drug prices, as patients fall into the yawning gap between what the NHS can Read the full story

Shared from Apple News